オプションチェーンは、Tenaya Therapeuticsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Tenaya Therapeuticsの市場センチメントを評価します。.

Tenaya Therapeutics (NASDAQ:TNYA) 株価情報, オプションチェーン

Tenaya Therapeutics

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.

Tenaya Therapeutics Inc

WIIM

TSLA

Tesla shares are trading lower after the company saw a drop in new car registrations in January in the European Union.

DA Davidson analyst Peter Heckmann maintains CPI Card (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMTS#NASDAQ">PMTS</a>) with a Buy and maintains $36 price target.

News

Price Target

Analyst Ratings

PMTS

DA Davidson Maintains Buy on CPI Card, Maintains $36 Price Target

While some traders remain hopeful for <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43819775/altcoins-face-insane-volatility">an altcoin rally</a>, crypto chart analyst Ali Martinez warns that current market conditions don't favor it.
What Happened: In a detailed post on <a href="https://x.com/ali_charts/status/1893290500477571123">X</a> on Feb. 22, Martinez laid out a harsh reality—altcoin season isn&#8217;t taking off.
That is not due to lack of potential, but because the conditions no longer align. Over 36 million tokens in existence have means the market is oversaturated, while liquidity is drying up. 
Between January and April 2024 alone, over $25 billion worth of new tokens were unlocked, flooding the market with excess supply.
Capital inflows have plunged by 70% since December, leaving the market vulnerable to manipulation.
Even major bullish catalysts—such as <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43836911/trump-reiterates-resolve-to-make-us-the-crypto-capital-critic-labels-idea-of-bitcoin-reserve-legislation-absurd">Trump's pro-crypto stance</a>, <a href="https://www.benzinga.com/content/43615709/solana-could-surge-in-price-while-sec-evaluates-grayscales-etf-proposal-could-this-propel-panshibi-t">ETF discussions</a> for Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), and XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), and <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43741884/abu-dhabi-wealth-fund-buy-437-millions-worth-of-blackrocks-bitcoin-etf">sovereign wealth funds accumulating</a> Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)—haven't been able to boost prices. 
Lawsuits against Coinbase, Kraken, and Uniswap being dismissed added to optimism but failed to trigger significant rallies.
At the same time, negative news like the $1.46 billion Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) hack, meme coin scams and Solana's upcoming $2 billion token unlocks have weighed heavily on sentiment—reminiscent of late-stage bull markets in 2021.
Also Read: <a href="https://in.benzinga.com/markets/cryptocurrency/25/02/43819775/altcoins-face-insane-volatility">Altcoins Face &#8216;Insane Volatility&#8217; And &#8216;Super Negative&#8217; Sentiment—But &#8216;Better Days Are Coming,&#8217; Says Trader</a>
What's Next: Martinez believes the current market calls for precision trading—waiting for ideal setups, avoiding emotional decisions, and only executing high-probability trades. 
He warns that 2025 is about taking profits, not investing, revealing that he has already sold 80% of his Bitcoin.
"Liquidity is disappearing, sentiment is shifting, and the easy money has already been made," Martinez stated. While he sees risks outweighing rewards for holding Bitcoin, he doesn't completely rule out the possibility of a market rally.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43877698/alt-season-has-begun-expert-says-but-will-ethereum-xrp-solana-benefit">&#8216;Alt Season Has Begun,&#8217; Expert Says, But Will Ethereum, XRP, Solana Benefit?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SOL

$XRP

'Liquidity Is Disappearing': Bitcoin's Downturn Spells Doom For Altcoins, Analyst Warns

Citizens Capital Markets analyst Patrick Walravens reiterates Zoom Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) from Market Perform to Market Perform.

Reiteration

Citizens Capital Markets Reiterates Market Perform on Zoom Communicationsto Market Perform

DA Davidson analyst Jeff Rulis maintains First Busey (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BUSE#NASDAQ">BUSE</a>) with a Neutral and maintains $25 price target.

BUSE

DA Davidson Maintains Neutral on First Busey, Maintains $25 Price Target

Citizens Capital Markets analyst Trevor Walsh reiterates V2X (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVX#NYSE">VVX</a>) with a Market Outperform and maintains $80 price target.

Citizens Capital Markets Reiterates Market Outperform on V2X, Maintains $80 Price Target

Huawei Technologies Co has significantly improved the amount of <a target="_blank" href="https://www.benzinga.com/news/24/10/41119735/nvidia-faces-new-competition-cerebras-files-for-ipo-huawei-pushes-ai-chips" rel="noreferrer noopener">advanced artificial intelligence chips</a> it can produce. The Chinese information and communications technology (ICT) infrastructure and smart devices provider has increased the &#8220;yield&#8221; or the percentage of functional chips made on the production line of its latest AI chips to ~40%, doubling from 20% about a year ago, the Financial Times <a target="_blank" href="https://www.ft.com/content/f46b7f6d-62ed-4b64-8ad7-2417e5ab34f6" rel="noreferrer noopener">reported</a>, citing unnamed sources familiar with the matter.
The improved yield means that <a target="_blank" href="https://www.benzinga.com/markets/emerging-markets/25/01/43096797/huawei-wants-to-take-nvidias-place-in-ai-in-china-shifts-focus-to-inference-over-training" rel="noreferrer noopener">Huawei&#8217;s production line</a> for Ascend chips has become profitable for the first time, the FT cited unnamed sources familiar with the matter.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/emerging-markets/25/02/43691826/not-just-deepseek-chinas-ai-landscape-heats-up-as-baidu-launches-free-ernie-bot" rel="noreferrer noopener">Not Just DeepSeek, China&#8217;s AI Landscape Heats Up As Baidu Launches Free Ernie Bot</a>
The company aims to improve yields to 60%, the industry standard for similar chips. Huawei currently accounts for more than three-quarters of the overall output of AI chips in China, the FT cited unnamed sources familiar with the matter.
Beijing urged local tech companies to buy more of Huawei&#8217;s AI chips and shift away from the U.S. chipmaker Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), which remains the market leader in China by far.
Nvidia dominates the AI chip market as Huawei struggles to <a target="_blank" href="https://www.benzinga.com/news/24/09/40692210/nvidia-maintains-ai-chip-dominance-as-huawei-struggles-to-compete-report" rel="noreferrer noopener">match CUDA&#8217;s efficiency</a> despite efforts to compete with its Ascend series.
Washington forced contract chip manufacturer Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) to stop making Ascend and advanced smartphone chips in 2020 after the country blocked Huawei from accessing U.S. technology manufacturing.
Austin Lyons of Creative Strategies compared Huawei&#8217;s production to Taiwan Semiconductor&#8217;s estimated 60% yield for producing Nvidia&#8217;s H100 AI processor.
Huawei tapped the sanctioned Chinese fabrication group Semiconductor Manufacturing International Corp to relaunch its Ascend chip. The U.S. sanctions prohibited China from procuring advanced chipmaking equipment from the Dutch group ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>).
Huawei plans to produce 100,000 910C processors and 300,000 910B chips this year, the FT cited unnamed sources familiar with the matter.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43920072/taiwan-semiconductor-poised-for-surge-goldman-sachs-predicts-rising-demand-for-taipei-traded-shares" target="_blank" rel="noreferrer noopener">Taiwan Semiconductor Poised For Surge, Goldman Sachs Predicts Rising Demand For Taipei-Traded Stock: Report</a></li>
</ul>
Image via Shutterstock

Asia

Emerging Markets

Tech

Media

ASML

NVDA

Huawei Boosts AI Chip Production Despite Taiwan Semi And ASML Ban, Aims to Challenge Nvidia In China

DA Davidson analyst Kurt Yinger maintains Trex Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TREX#NYSE">TREX</a>) with a Neutral and maintains $74 price target.

TREX

DA Davidson Maintains Neutral on Trex Co, Maintains $74 Price Target

Whales with a lot of money to spend have taken a noticeably bearish stance on Goldman Sachs Gr.
Looking at options history for Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) we detected 47 trades.
If we consider the specifics of each trade, it is accurate to state that 34% of the investors opened trades with bullish expectations and 44% with bearish.
From the overall spotted trades, 21 are puts, for a total amount of $3,179,021 and 26, calls, for a total amount of $4,725,764.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $350.0 to $820.0 for Goldman Sachs Gr during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Goldman Sachs Gr's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Goldman Sachs Gr's whale activity within a strike price range from $350.0 to $820.0 in the last 30 days. 
<h3>Goldman Sachs Gr Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740499311_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GS</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$31.25</td>
<td>$30.65</td>
<td>$30.9</td>
<td>$600.00</td>
<td>$1.5M</td>
<td>1.2K</td>
<td align="right">514</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$176.55</td>
<td>$171.0</td>
<td>$173.69</td>
<td>$460.00</td>
<td>$1.3M</td>
<td>73</td>
<td align="right">75</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$169.6</td>
<td>$164.2</td>
<td>$166.99</td>
<td>$450.00</td>
<td>$1.2M</td>
<td>213</td>
<td align="right">75</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$20.95</td>
<td>$20.5</td>
<td>$20.9</td>
<td>$700.00</td>
<td>$418.0K</td>
<td>316</td>
<td align="right">200</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$41.75</td>
<td>$41.0</td>
<td>$41.63</td>
<td>$640.00</td>
<td>$332.6K</td>
<td>219</td>
<td align="right">82</td>
</tr>
</tbody>
</table>

<h3>About Goldman Sachs Gr</h3>
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 20% of its revenue comes from investment banking, 45% from trading, 20% from asset management and 15% from wealth management and retail financial services. Around 60% of the company's net revenue is generated in the Americas, 15% in Asia, and 25% in Europe, the Middle East, and Africa.
<h3>Current Position of Goldman Sachs Gr</h3>
<ul>
<li>With a trading volume of 657,909, the price of GS is down by -1.84%, reaching $614.63.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 48 days from now.</li>
</ul>
<h3>What The Experts Say On Goldman Sachs Gr</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $720.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Goldman Sachs Gr, which currently sits at a price target of $720. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Goldman Sachs Gr, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

Goldman Sachs Gr Options Trading: A Deep Dive into Market Sentiment

Deep-pocketed investors have adopted a bullish approach towards Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CVNA usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 38 extraordinary options activities for Carvana. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 39% leaning bullish and 39% bearish. Among these notable options, 24 are puts, totaling $1,457,873, and 14 are calls, amounting to $1,158,163.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $150.0 to $370.0 for Carvana over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Carvana's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Carvana's substantial trades, within a strike price spectrum from $150.0 to $370.0 over the preceding 30 days.
<h3>Carvana 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740499306_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/28/25</td>
<td>$7.2</td>
<td>$6.05</td>
<td>$6.65</td>
<td>$215.00</td>
<td>$324.5K</td>
<td>231</td>
<td align="right">635</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/28/25</td>
<td>$4.6</td>
<td>$4.15</td>
<td>$4.15</td>
<td>$220.00</td>
<td>$173.7K</td>
<td>718</td>
<td align="right">473</td>
</tr>
<tr>
<td>CVNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$26.35</td>
<td>$25.15</td>
<td>$25.4</td>
<td>$240.00</td>
<td>$132.2K</td>
<td>1.2K</td>
<td align="right">166</td>
</tr>
<tr>
<td>CVNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$45.25</td>
<td>$44.6</td>
<td>$44.6</td>
<td>$230.00</td>
<td>$129.3K</td>
<td>33</td>
<td align="right">38</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$3.3</td>
<td>$3.15</td>
<td>$3.3</td>
<td>$225.00</td>
<td>$127.0K</td>
<td>1.3K</td>
<td align="right">442</td>
</tr>
</tbody>
</table>

<h3>About Carvana</h3>
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.
<h3>Where Is Carvana Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,596,342, with CVNA's price up by 0.13%, positioned at $215.92.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 64 days.</li>
</ul>
<h3>What The Experts Say On Carvana</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $304.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from DA Davidson persists with their Neutral rating on Carvana, maintaining a target price of $260. 
&#x2A; An analyst from RBC Capital persists with their Outperform rating on Carvana, maintaining a target price of $320. 
&#x2A; In a cautious move, an analyst from Stephens &amp; Co. downgraded its rating to Overweight, setting a price target of $300. 
&#x2A; An analyst from Stephens &amp; Co. downgraded its action to Overweight with a price target of $300. 
&#x2A; Consistent in their evaluation, an analyst from Needham keeps a Buy rating on Carvana with a target price of $340. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Carvana with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

CVNA

Decoding Carvana's Options Activity: What's the Big Picture?

Financial giants have made a conspicuous bearish move on Bitdeer Technologies. Our analysis of options history for Bitdeer Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) revealed 19 unusual trades.
Delving into the details, we found 42% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we spotted, 16 were puts, with a value of $6,762,010, and 3 were calls, valued at $165,250.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $5.0 to $25.0 for Bitdeer Technologies over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Bitdeer Technologies stands at 2089.89, with a total volume reaching 19,262.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Bitdeer Technologies, situated within the strike price corridor from $5.0 to $25.0, throughout the last 30 days.
<h3>Bitdeer Technologies Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740499301_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BTDR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$15.3</td>
<td>$14.9</td>
<td>$15.2</td>
<td>$25.00</td>
<td>$1.5M</td>
<td>5.1K</td>
<td>4.0K</td>
</tr>
<tr>
<td>BTDR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$15.1</td>
<td>$14.9</td>
<td>$15.0</td>
<td>$25.00</td>
<td>$1.4M</td>
<td>5.1K</td>
<td>1.0K</td>
</tr>
<tr>
<td>BTDR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$15.1</td>
<td>$15.0</td>
<td>$15.1</td>
<td>$25.00</td>
<td>$1.4M</td>
<td>5.1K</td>
<td>1.9K</td>
</tr>
<tr>
<td>BTDR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$15.3</td>
<td>$15.0</td>
<td>$15.1</td>
<td>$25.00</td>
<td>$755.0K</td>
<td>5.1K</td>
<td>2.0K</td>
</tr>
<tr>
<td>BTDR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/28/25</td>
<td>$5.1</td>
<td>$4.9</td>
<td>$4.9</td>
<td>$14.50</td>
<td>$412.5K</td>
<td>4.5K</td>
<td>842</td>
</tr>
</tbody>
</table>

<h3>About Bitdeer Technologies</h3>
Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway.
After a thorough review of the options trading surrounding Bitdeer Technologies, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Bitdeer Technologies Standing Right Now?</h3>
<ul>
<li>With a trading volume of 8,396,891, the price of BTDR is down by -26.56%, reaching $9.62.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 0 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Bitdeer Technologies</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $30.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Rosenblatt persists with their Buy rating on Bitdeer Technologies, maintaining a target price of $30. 
&#x2A; Maintaining their stance, an analyst from Rosenblatt continues to hold a Buy rating for Bitdeer Technologies, targeting a price of $30. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Bitdeer Technologies with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

BTDR

Bitdeer Technologies's Options: A Look at What the Big Money is Thinking

Citizens Capital Markets analyst Mikhail Goberman reiterates UWM Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UWMC#NYSE">UWMC</a>) from Market Perform to Market Perform.

UWMC

Citizens Capital Markets Reiterates Market Perform on UWM Hldgsto Market Perform

TRTX

TPG RE Finance Trust Option Alert: Jan, 2027 $7 Calls Sweep (34) near the Ask: 395 @ $1.8 vs 2 OI; Ref=$8.48

Primerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRI#NYSE">PRI</a>) has outperformed the market over the past 10 years by 7.08% on an annualized basis producing an average annual return of 17.97%. Currently, Primerica has a market capitalization of $9.18 billion. 
Buying $1000 In PRI: If an investor had bought $1000 of PRI stock 10 years ago, it would be worth $5,199.51 today based on a price of $275.22 for PRI at the time of writing.
<h3>Primerica's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740499211_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Primerica 10 Years Ago Would Be Worth This Much Today

DA Davidson analyst Brent Thielman maintains Primoris Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRIM#NYSE">PRIM</a>) with a Buy and maintains $85 price target.

PRIM

DA Davidson Maintains Buy on Primoris Services, Maintains $85 Price Target

Citizens Capital Markets analyst Reni Benjamin reiterates Summit Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) with a Market Outperform and maintains $32 price target.

SMMT

Citizens Capital Markets Reiterates Market Outperform on Summit Therapeutics, Maintains $32 Price Target

Truist Securities analyst Peter Osterland maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Buy and lowers the price target from $168 to $166.

Truist Securities Maintains Buy on Westlake, Lowers Price Target to $166

DA Davidson analyst Michael Shlisky maintains Douglas Dynamics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLOW#NYSE">PLOW</a>) with a Buy and maintains $32 price target.

PLOW

DA Davidson Maintains Buy on Douglas Dynamics, Maintains $32 Price Target

Citizens Capital Markets analyst David Turkaly reiterates SI-BONE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIBN#NASDAQ">SIBN</a>) with a Market Outperform and maintains $32 price target.

SIBN

Citizens Capital Markets Reiterates Market Outperform on SI-BONE, Maintains $32 Price Target

Truist Securities analyst Keith Hughes maintains Trex Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TREX#NYSE">TREX</a>) with a Buy and lowers the price target from $100 to $90.

Truist Securities Maintains Buy on Trex Co, Lowers Price Target to $90

Earnings

Press Releases

Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Tenaya Therapeutics to Participate in Upcoming Investment Conferences

Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM

Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Health Care

Tenaya Therapeutics Doses First Patient in RIDGE™-1 Phase 1b Clinical Trial of TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024

Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

Comments

Tenaya Therapeutics

Tenaya Therapeutics (TNYA) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル